Company moves to bigger grounds!, page-122

First 122 Last

Share
Profile

Follow
lexcorp

7,962 Posts.

502

23/11/15

18:22

Post #: 16458539
Share

Originally posted by bang ↑

Which we can extrapolate forward knowing we have sold over $2.5m worth of cardiocel already as Rodne said in the AGM. Nobody will get the same answer as we extrapolate differently depending on how we see the centre uptake taking off. Unfortunately, all who is saying this is overvalued seem to be looking at this TODAY and not the future and most who say this is undervalued can't give proper reasoning- except the odd few. Their is only one main reason why this isn't going anywhere and that is because management will not give us the future revenue guide they expect.. Without this, we are out on a limb and we can only use our best guesstimates. Our vaccine division must be worth something, calculate the $ per last % we paid and work out the value of our vaccine division, nothing that has been worked on for this long should be worth $0. But the market wont ascribe value to it until they see positive phase 2 results because if the market believes you have a 50% chance of failure then the price is worth $0... What they might not understand is how this platform can be used for other things... again same argument though, worth nothing till proven.. especially in the ASX.

We need to see a very big % increase in cardiocel numbers this quarter and the next in order to move the price. I hope Admedus can saturate it into 200 centres by December 31st this year and also partner up on their next adapt product as well as a partner for the vaccine.

Expand

Bang,
Extrapolate for us then.

AHZ Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

There are more pages in this discussion • 12 more messages in this thread...

First 122 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $17.97		Change -0.235(1.29%)		Mkt cap ! $345.3M

Open	High	Low	Value	Volume
$18.09	$18.09	$17.88	$1.182K	66

Buyers (Bids)

No.	Vol.	Price($)
1	60	$17.88

Sellers (Offers)

Price($)	Vol.	No.
$18.05	554	1

View Market Depth

No.	Vol.	Price($)
1	60	17.880
1	47	17.870
1	619	17.860
1	37	17.650
2	700	17.550

Price($)	Vol.	No.
18.050	554	1
18.100	1000	1
18.200	343	2
18.300	150	1
18.500	43	1

Last trade - 14.30pm 10/07/2024 (20 minute delay)

AVR (ASX) Chart

Company moves to bigger grounds!, page-122

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Greentech finds lithium trend across 5.5 km at WA's Kobe South

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Company moves to bigger grounds!, page-122

Top Stories

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Greentech finds lithium trend across 5.5 km at WA's Kobe South

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News